Scribd Logo
Fazer o upload

Bem-vindo(a) ao Scribd!

  • Phizer Viagra

    Enviado por

    dacchu
    11 visualizações3 páginas
    China represents a large but challenging pharmaceutical market for Pfizer due to weak intellectual property protection enforcement, rampant counterfeiting, and competitive generic drug producers. After Pfizer's Viagra patent, multiple Chinese companies planned to launch generic versions. Pfizer needs a strategy that understands Chinese regulations and forms local partnerships to protect its brand from widespread copying in this high-stakes environment.

    Descrição original:

    Viagra Case

    Direitos autorais

    © © All Rights Reserved

    Formatos disponíveis

    PPTX, PDF, TXT ou leia online no Scribd

    Você considera este documento útil?

    Este conteúdo é inapropriado?

    Denunciar este documento
    China represents a large but challenging pharmaceutical market for Pfizer due to weak intellectual property protection enforcement, rampant counterfeiting, and competitive generic drug producers. After Pfizer's Viagra patent, multiple Chinese companies planned to launch generic versions. Pfizer needs a strategy that understands Chinese regulations and forms local partnerships to protect its brand from widespread copying in this high-stakes environment.

    Direitos autorais:

    © All Rights Reserved
    Baixe no formato PPTX, PDF, TXT ou leia online no Scribd
    Sinalizar o conteúdo como inadequado
    11 visualizações3 páginas

    Phizer Viagra

    Enviado por

    dacchu
    China represents a large but challenging pharmaceutical market for Pfizer due to weak intellectual property protection enforcement, rampant counterfeiting, and competitive generic drug producers. After Pfizer's Viagra patent, multiple Chinese companies planned to launch generic versions. Pfizer needs a strategy that understands Chinese regulations and forms local partnerships to protect its brand from widespread copying in this high-stakes environment.

    Direitos autorais:

    © All Rights Reserved
    Baixe no formato PPTX, PDF, TXT ou leia online no Scribd
    Sinalizar o conteúdo como inadequado
    de 3

    Environmental Analysis

    • China is worlds ninth largest pharmaceutical Market


    • Weak IPR Protection enforcement system
    • Highly competitive market
    • Enormous presence of counterfeiters
    • Developing economy which was adapting Trade Related Intellectual-Property Rights(TRIPS) of WTO
    Competitor Analysis

    • After Pfizer was granted Viagra patent, a Beijing resident Pan Huapin challenged it
    • Later 12 companies named Tonghua Hongtaomao Pharmaceutical Co., Lianxiang Pharmaceutical Co.,
    Guangzhou Baiyunshan Pharmaceutical Co., Shuanglong Hi-Tech Development Co. Ltd., and others joined
    them
    • Bayer AG and Eli Lilly & Co were manufacturing alternative ED drugs such as Levitra and Cialis
    • The Weige Alliance headed by Tonghua Hongtaomao Pharmaceutical Co., planned to launch the generic
    version of Viagra.
    • Guangzhou Viaman Pharmaceutical Company also started selling Viagra
    • Beijing Health New Concept Pharmaceutical Co Ltd and Lianhuan Pharmaceutical Co Ltd were selling viagra
    under the brand name ‘Wei Ge’
    Strategy Formulation

    • Pfizer should first understand China’s Rules and Regulation so that they can handle the legal issues
    • It should have done proper analysis of all the factors which affects the business before entering into the
    market
    • Should have formed an strategic alliance with an strong branded existing company in the market
    • Product Line extension
    • Effective pricing strategy

    Você também pode gostar